Asthma Facts
PIco de gallo
Potent Potables
Jump to Conclusions
100

The highest asthma prevalence rates in the US are seen in these 2 groups.

Puerto Ricans and Blacks

100

What was the patient population?

Adults 18-75yo w/ MILD asthma.

-Use of SABA as sole therapy in previous 3 months & use of SABA on at least 2 occasions, but on average of two or fewer occasions per day in previous 4 weeks.

-No minimum requirement for SABA use on those w/ severe exacerbation in previous 12 months.

100

Definition of an open label trial

Information is not withheld from trial participants - both the researchers and participants know which treatment is being administered

100

This is the sample size of the study that underwent analysis.

668 patients

The 3 groups were essentially equally randomized.

200

This medication has bronchodilator activity in acute asthma, possibly due to inhibition of calcium influx into airway smooth muscle cells.

Magnesium Sulfate

2g IV over 20 mins as adjunctive therapy for severe life-threatening exacerbations and for exacerbations that remain severe after 1 hr of intensive conventional therapy.

200

Exclusion criteria for the study

Hospitalization for asthma in the previous 12 months and either a patient-reported smoking history of more than 20 pack-years or the onset of respiratory symptoms after the age of 40 years in current or previous smokers with a smoking history of at least 10 pack-years

200

What type of trial was this?  Be specific.

Randomized, open-label, parallel-group, controlled trial.

This was an intention to treat study design.

200

This was anticipated dropout rate.

20%.

13 patients were lost to follow-up.

71 patients had treatment failure and were withdrawn. 

Actual 'drop-out' rate 12.5%

300

During intubation, this neuromuscular blocking agent should be avoided due to its release of appreciable amounts of histamine.


Bonus: Name a commonly used option in asthmatics.

Avoid succinylcholine or atracurium.

Rocuronium preferred.  Cisatracurium or vecuronium also options.


300

Identify the intervention/comparison.

1:1:1 ratio of the following:

-albuterol PRN

-budesonide maintenance + albuterol PRN

-budesonide-formoterol

300

This is the thing that becomes toast.

What is bread?

300

Primary Outcome of this study

Annualized rate of asthma exacerbations per patient.

400

It's useful to measure this frequently in asthmatics so that your patient knows his/her baseline.

Peak Expiratory Flow

400

DAILY DOUBLE

Brand names of budesonide AND budesonide/formoterol.


Budesonide is Pulmicort.

Budesonide/Formoterol is Symbicort.

400

Secondary Outcomes of this study (name 3)

number of exacerbations

time to the first exacerbation

number of severe exacerbations

number of patients who were withdrawn as a result of treatment failure

score on the Asthma Control Questionnaire–5

on-treatment forced expiratory volume in 1 second (FEV1)

fraction of exhaled nitric oxide

the electronically recorded daily dose of budesonide

oral prednisone use (in milligrams)

the electronically recorded number of β2-agonist actuations per day

adverse events

500

A peak expiratory flow decrease of ___% from baseline may indicate an exacerbation.

10-20%

500

These patients were withdrawn for treatment failure. Name all scenarios.

1 severe exacerbation

3 exacerbations separated by at least 7 days

Unstable asthma resulting in medication changes

500

Ringo Starr narrated 'Thomas & Friends', a job later taken on by this comedian.

Who is George Carlin?

500

PRACTICE CHANGING GUIDELINES

True or False: This study resulted in change of the 2019 GINA asthma guidelines.

False.  GINA changed d/t SYGMA 1 & 2.  This study helps solidify the recommendations and was published after the guideline change. 

---------------------------------------------------------

In conclusion, this clinical trial, in which an open-label design was used to reflect clinical practice, showed that budesonide–formoterol used as needed was superior to albuterol used as needed for the prevention of exacerbations in adults with mild asthma but did not control symptoms better than maintenance therapy.